Related Experiment Videos
[Infectious endocarditis at Ullevål hospital 1988-94. Echocardiographic investigation]
T Husebye1, G Smith, E von der Lippe
1Hjertemedisinsk avdeling Medisinsk klinikk Ullevål sykehus Oslo.
Summary
Infectious endocarditis cases were analyzed, revealing Staphylococcus aureus as the leading cause. Despite advanced diagnostics, accurate clinical diagnosis remains a challenge, with significant differences in outcomes for S. aureus versus S. viridans infections.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Infectious endocarditis (IE) is a serious infection affecting heart valves.
- Accurate diagnosis and etiological identification are crucial for patient management.
- Echocardiography has improved diagnostic capabilities for IE.
Purpose of the Study:
- To analyze the clinical characteristics, etiological agents, and outcomes of infectious endocarditis.
- To evaluate the diagnostic challenges and effectiveness of echocardiography in IE.
- To compare case fatality rates between different etiological agents.
Main Methods:
- Retrospective analysis of 68 patients diagnosed with infectious endocarditis over a seven-year period (1988-1994).
- Identification of etiological agents, including Staphylococcus aureus and Streptococcus viridans.
- Review of diagnostic methods, including autopsy findings and echocardiography (transthoracic and transesophageal).
Main Results:
- Staphylococcus aureus (38%) and Streptococcus viridans (21%) were the most common pathogens.
- Case fatality was 34% overall, significantly higher for S. aureus (48%) vs. S. viridans (7%) endocarditis (p=0.01).
- 23% of patients lacked a definitive clinical diagnosis despite advanced imaging; 7 diagnoses were made post-mortem.
Conclusions:
- Staphylococcus aureus poses a higher mortality risk in infectious endocarditis compared to Streptococcus viridans.
- Echocardiography is valuable for IE diagnosis and follow-up, but clinical diagnosis remains challenging.
- Early and accurate diagnosis is critical for improving outcomes in infectious endocarditis.